BioMedWire Stocks Archives - Page 22 of 69

WednesdayFeb 28, 2024 9:45 am

Siteman Cancer Center Starts Offering Novel Cell-Based Immunotherapy Against Melanoma

Patients with melanoma may soon be able to access a new immunotherapy that was recently approved by the U.S. Food and Drug Administration (FDA). The cell-based treatment, which was developed by Iovance Therapeutics, will first be administered by physicians at the Siteman Cancer Center in Washington University before it can be commercialized under the name Amtagvi. The tumor-infiltrating lymphocyte immunotherapy has been designed for the treatment of metastatic melanoma, which is a skin cancer that has spread to other parts of the body. The treatment, called lifileucel, has been designed specifically for patients suffering from this particular cancer whose tumor…

MondayFeb 26, 2024 9:30 am

Study Shows Troops That Sustain Serious Brain Injuries Have Higher Risk of Brain Cancer

Figures show that brain cancer occurs in less than 1% of the population in America. At least one-third of individuals diagnosed with primary brain cancer tumors survive for at least five years. Those with glioblastoma, a common type of brain cancer, have about a 14% chance of living an additional five years. This is dependent on the age of diagnosis, however. While what causes brain cancer is still unknown, scientists theorize that exposure to ionized radiation may be linked to this illness. Now, new research has found that veterans who experience head injuries have a heightened risk of developing brain…

FridayFeb 23, 2024 10:00 am

Challenges Faced in Upholding Medical Ethics in Safety-Net Healthcare Systems

Safety-net health systems are critical to providing adequate healthcare to underserved populations such as ethnic or racial minorities and uninsured and low-income individuals. A September 2023 Census Bureau report noted that 7.9% of the American population, or 26 million people, were uninsured in 2022. Several studies have also shown that racial and ethnic minorities are more likely to face challenges when trying to access medical care in North America. Black, Hispanic and Asian populations appear to have lower access to health insurance coverage in the United States, with Hispanic individuals reportedly facing more significant barriers to accessing health insurance. Safety-net…

WednesdayFeb 21, 2024 10:00 am

FDA Grants Florida Permission to Import More Affordable Medicines from Canada

The FDA recently approved a plan that permits the state of Florida to import some drugs from Canada at lower prices than the medications that can be acquired in America. It is a well-known fact that the cost of drugs in the United States is high, with numerous studies finding that in comparison to other developed countries, America spends significantly more on prescription medications. One analysis by the Government Accountability Office determined that the prices of most prescribed medications were almost three times higher in America than in Canada. Various factors help determine the exact amount every patient pays for…

FridayFeb 16, 2024 9:45 am

Study Links Microbiome Composition to Autism Spectrum Disorder

Israeli researchers have discovered a potential link between microbiome composition and autism spectrum disorder (ASD). Autism is a neurodevelopmental condition that causes repetitive behaviors and decreased social communication in affected individuals. Scientists have spent the past few decades trying to learn about the underlying mechanisms that trigger the condition and its symptoms. Although research shows that cases of autism spectrum disorder are on the rise, scientists still don’t understand what causes the neurodevelopmental disorder. Some posit that rare gene mutations or changes coupled with small genetic variations in ASD patients may be responsible for causing the condition. Researchers from Bar-Ilan…

WednesdayFeb 14, 2024 10:00 am

Study Links Ramadan Fasting to Lower Risk of Chronic Disease Development

A recent study has revealed that Ramadan fasting may be associated with a lower risk of developing chronic diseases. Published in the “American Journal of Clinical Nutrition,” the study found that Ramadan fasting was linked with a significant reduction in the risk of breast, colorectal and lung cancers. Researchers collected data from 72 participants from the London Ramadan Study (LORANS), an observational cohort of 140 Muslims who follow the annual Ramadan fast. Ramadan typically involves avoiding all food and drink from before the day’s first light till the sun sets on a specific set of days every year. The researchers…

MondayFeb 12, 2024 9:45 am

New MRI Procedure Eases Multiple Sclerosis Diagnosis

Researchers from ETH Zurich have developed a new magnetic resonance imaging (MRI) technique that can ease multiple sclerosis diagnosis and produce more accurate findings. Led by Emily Baadsvik and Markus Weiger from ETH Zurich’s Institute for Biomedical Engineering, the research team created a technique to map myelin sheath conditions for more accurate diagnoses. Multiple sclerosis (MS) is a potentially disabling neurological condition that affects the central nervous system (brain and spinal cord). It occurs when the immune system becomes dysfunctional and starts to attack myelin, the protective sheath that covers and protects nerve fibers, resulting in communication problems between the…

FridayFeb 09, 2024 11:00 am

The Right to Health During Humanitarian Crises Should Include Noncommunicable Diseases

Estimates from the United Nations show that about 363 million individuals worldwide are affected by humanitarian crises driven by the climate crisis, increase conflict and fragility, and broadening inequality. In 2022, more than 108 million individuals were forced to flee their homes due to conflict. While humanitarian crises such as those currently occurring in Gaza, Sudan, Libya, Somalia and Ukraine may vary in scale and nature, they all share infrastructure demolition, displacement of the masses, and the disruption of services and supply chains. Healthcare facilities are also heavily impacted in times of conflict, particularly because they are directly targeted. Access…

WednesdayFeb 07, 2024 10:15 am

Patients with Swelling Disorder See New Gene Therapy as Godsend

A new gene therapy is transforming the lives of patients with a debilitating hereditary condition that causes painful and even fatal levels of swelling. The therapy led to significantly promising results in its first trial involving humans, with patients involved in the study reporting “dramatic improvements” in their symptoms that allowed them to stop taking long-term medication and resume their regular day-to-day activities. Hereditary angioedema is a rare condition that arises from a genetic mutation and causes leaky blood vessels in patients. This leads to random bouts of swelling that can affect the hand, feet, throat, bowels, mouth and lips…

TuesdayFeb 06, 2024 11:45 am

How AI Could Revolutionize Personalization in e-Commerce

According to a 2021 study by McKinsey & Company, 71% of customers expect companies to deliver personalized experiences while 78% choose to pay higher prices for personalized services or custom services. The study revealed that companies with great personalization earn roughly 40% more revenue from personalization-related activities compared to companies with average personalization. The research also found that 75% of customers recently tried a new shopping behavior, indicating that it is getting increasingly hard for brands to gain and retain customer loyalty. Personalization has become very important to customers who, on average, expect some degree of personalization in their interactions…